Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Editorial
Nature Reviews Clinical Oncology 5, 363 (1 July 2008) | doi:10.1038/ncponc1177
Lost in translation|[mdash]|prognostic signatures for breast cancer
Abstract
The number of prognostic gene signatures reported for breast cancer has increased dramatically in the past 5 years. The use of genomic prognostic assays, however, remains low, both in routine practice and in clinical trials.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
